Detailed answers about LIGHTHOUSE THERAPEUTICS LIMITED, including incorporation, status, business activity, and accounts information.
When was LIGHTHOUSE THERAPEUTICS LIMITED founded?
LIGHTHOUSE THERAPEUTICS LIMITED was officially incorporated on 15 March 2023 and is registered under company number 14732624. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is LIGHTHOUSE THERAPEUTICS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of LIGHTHOUSE THERAPEUTICS LIMITED?
LIGHTHOUSE THERAPEUTICS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does LIGHTHOUSE THERAPEUTICS LIMITED do?
LIGHTHOUSE THERAPEUTICS LIMITED operates in the following sectors: 20590 - Manufacture of other chemical products n.e.c., 46750 - Wholesale of chemical products, 72110 - Research and experimental development on biotechnology, 74909 - Other professional, scientific and technical activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is LIGHTHOUSE THERAPEUTICS LIMITED's registered address?
The registered office address of LIGHTHOUSE THERAPEUTICS LIMITED is 34-36 GRAND PARADE, EASTBOURNE, ENGLAND, BN21 3YT. This is the official address filed with Companies House for legal and statutory correspondence.
Is LIGHTHOUSE THERAPEUTICS LIMITED financially stable?
The most recent accounts for LIGHTHOUSE THERAPEUTICS LIMITED were made up to 31 March 2025, filed as MICRO ENTITY. Next accounts are due by 31 December 2026.